Patent · US Active

Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cells

US10329353B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2014
Grant dateJun 25, 2019
Priority date
Expiry dateMay 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention includes the discovery of cell-surface vimentin as a novel biomarker to detect and isolate mesenchymal and epithelial-mesenchymal transformed circulating tumor cells from blood of cancer patients. In addition, an antibody specific for the detection of cell-surface vimentin on circulating tumor cells and the use the antibody to detect, enumerate, and isolate CTC are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.